There are two kinds of people, those who do the work and those who take the credit. Try to be in the first group; there is less competition there.
– Indira Gandhi, The most dynamic woman of the twentieth century
Don’t be a know-it-all; be a learn-it-all.
– Satya Nadella, CEO, Microsoft
Principal Investigators
- Butler University
- Distinguished Faculty, 2023
- Professor, 2015 – present
- Associate Professor (tenured), 2004 – 15
- Department Chair, 2004-09
- Director of Graduate Program, 2004-18
- Indiana University, School of Medicine
- Adjunct Professor, Dept of Radiology & Imaging Sciences, 2019-2023
- Idaho State University
- Associate Professor (tenured 2003), 1998-2004
- Nova Southeastern University
- Assistant Professor, 1993-98
- Memorial University of Newfoundland, Canada
- Assistant Professor, 1991-93
- University of Queensland, Australia
- UQ PostDoctoral Fellow, 1990-91
- Butler University
- Professor, 2018 – present
- Associate Professor, 2005-2018 (tenured 2012)
- Research Associate Professor, 2004-05
- Idaho State University
- Assistant Professor, 1998-2004
- Nova Southeastern University
- Adjunct Assistant Professor, 1997-98
- Eckerd Drug Corporation (Rite Aid), Plantation, FL
- Staff Pharmacist, 1995-98
- SmithKline Beecham Pharmaceuticals (Glaxo SmithKline), King of Prussia, PA
- Graduate Scholar and Research Assistant, 1993-95
Collaborator
Michael C. Veronesi, MD, PhD, Assistant Professor of Radiology & Imaging Sciences
Indiana University School of Medicine, Indianapolis, IN
Current member of the lab
Name | Research project |
---|---|
Max Singh |
Former members of the lab
Name | Role | Research Project | Current affiliation |
---|---|---|---|
Dr. Sarat Chattaraj | Postdoctoral Fellow | Oral delivery of microparticulate vaccines | Senior Principal Scientist at Viatris (Mylan Pharmaceuticals), Morgantown, WV |
Dr. Prabhakar Reddy | Postdoctoral Fellow – funded by NIH-NIDA 2005-06 | Mucoadhesive buprenorphine for opioid addiction therapy – funded by NIDA | Principal, University College of Pharmaceutical Sciences, Palamuru University, Telangana, India |
Dr. Vijay Sutariya | Postdoctoral Fellow – funded by NIH-NIGMS 2007-08 | Lymphatic targeted tamoxifen for breast cancer therapy | Associate Professor, College of Pharmacy, University of South Florida, USA |
Ms. Kanako Somatsu | MS graduate, 2007 | Liposomal delivery of siRNA for silencing of the presenilin-1 gene responsible for development of Alzheimer’s disease | Senior Product Manager, Boston Scientific, Tokyo, Japan |
Ms. Sharmeen Rafique | MS graduate, 2008 | Development of submicron emulsion formulations of doxorubicin and cyclosporine for reversal of multidrug resistance and cell survival studies in MES/SA-Dx5 cell lines | CEO, Laminos Laboratories Pvt. Ltd, Mumbai, India |
Dr. Sheetal DeMello, AAPS-AstraZeneca Award, 2007 | MS graduate, 2009 | Development of paclitaxel and cyclosporine A loaded PEG-PLGA nanoparticles for reversal of multidrug resistance in MES-SA/Dx5 cells | Senior Scientist at Sangamo Therapeutics, Inc., CA |
Dr. Amit Kumar | MS graduate, 2009 | Development and evaluation of thermoreversible gels for nasal drug delivery of troglitazone and insulin for Alzheimer’s disease | Lead Scientist, Bristol-Myers Squibb, NJ |
Ms. Satwati Shukla, | MS graduate, 2011 | Development of nanoparticulate formulations of the antiangiogenic drug sunitinib maleate and their Influence on cell survival in human umbilical vein endothelial cells | |
Ms. Ruchi Kapoor, AAPS – AstraZeneca Award, 2009 | MS graduate, 2011 | Influence of co-formulated submicron emulsions of vincristine and cyclosporine on Cell survival in multidrug resistant MES-SA/Dx5 cells | Director of Product @SAP, CA |
Ms. Yatri Patel, AAPS-Amgen Award, 2011 | MS graduate, 2012 | Aptamer conjugated PEG-PLGA nanoparticles for delivery of docetaxel to MUC-1 positive cancer cells | Scientist, Pfizer Inc, Andover, MA |
Dr. Jainik Panchal | MS graduate, 2013 | Preparation and characterization of sunitinib magnetoliposomes as a model for theranostic nanomedicine | Principal Scientist, Merck Inc, NJ |
Ms. Neelima Mantha, AAPS-Amgen Award, 2011 | MS graduate, 2013 | Inhibition of mutant Huntingtin protein with liposomal siRNA in inducible PC-12 Cells | Senior Research Associate, Genentech-Roche, CA |
Mr. Shounak Bose | MS graduate, 2014 | Ocular Formulation of a Poorly Soluble New Chemical Entity for the Treatment of Age-Related Macular Degeneration | CEO, Indo-German Pharmaceuticals, India |
Mr. Rameej Kagdi | MS graduate, 2014 | Knockdown of Survivin Protein Expression Using Liposomal siRNA | Senior Scientist at Pfizer, Chicago, IL |
Ms. Puja Kanvinde | MS graduate, 2015 | Design of targeted iRGD peptide modified PLGA nanoparticles loaded with docetaxel and their effect on MDA-MB-231 breast cancer cells | Scientist, Study Coordination at Worldwide Clinical Trials, Austin, TX |
Dr. Sanika Rege | MS graduate, 2016 | Enhanced cytotoxicity via down-regulation of Survivin expression in MCF-7 and HeLa cells by PLGA-siRNA nanoparticles | Scientist, OPEN Health HEOR & Market Access |
Dr. Raj Kammari | MS graduate, 2017 | Co-delivery of Paclitaxel and Survivin siRNA using PLGA Nanoparticles Conjugated with iRGD Peptide | Scientist, Alexion Biopharm (Astra-Zeneca), CT |
Ms. Nikeeta Kheradia | MS graduate, 2017 | Lipid Nanoemulsion of Curcuminoid Enhances Cytotoxicity and Apoptosis in HeLa cells | R&D Scientist, Verdure Sciences, IN |
Dr. Nairrita Majumdar | MS graduate, 2018 | Enhanced Cytotoxicity and Apoptosis of Triple Negative MDA-MB-231 Cells with Docetaxel Loaded and Hyaluronic Acid Conjugated Polylactide-co-glycolide-Polyethylene Glycol Nanoparticles, with or without Co-administered iRGD Peptide | Postdoc fellow, UPMC, Pittsburgh, PA |
Ms. Rukmini Ladi | MS graduate, 2019 | Self-assembling Modified β-cyclodextrin Conjugated Nanoparticles and Liposomal siRNA Efficiently Knockdown the Mutant Huntingtin Gene in a Modified PC-12 Cell Line | External Collaborations Manager, Cell Therapy & Gene Therapy, Sartorius Stedim Biotech |
Ms. Tanvi Gandhi | MS graduate, 2019 | Smart Therapy: Co-administration of Cisplatin with CCND1 siRNA Loaded Liposomes for the Treatment of Mantle Cell Lymphoma (Co-Advisor: Dr. Masamha) | Associate Consultant Scientist, Eli Lilly & Co, IN |
Ms. Nayela Chowdhury AAPS Best Poster Awardee | MS graduate, 2019 | Formulation studies on paclitaxel nanomicelles and comparative evaluation of efficacy in 2D and 3D culture models of triple negative breast cancer cells | PhD candidate, Indiana University School of Medicine, IN |
Mr. Mohammad Ramadan, Fulbright Scholar from Egypt | MS graduate, 2020 | Low-temperature, Stress-free, Scalable Production of Docetaxel Folate-targeted Liposomes and their Physicochemical Evaluation | Production supervisor at Gypto Pharma, Egypt |
Mr. Victor Anguiano-Rosales | MS graduate, 2023 | Development of a nanoemulsion delivery system for nose-to-brain delivery of aripiprazole | Senior Associate Scientist R&D, Eli Lilly & Co, IN |
Dr. Ryan Dimmitt | PharmD, 2017, Cum Laude | Comparative study on the efficacy of cell-penetrating peptides, iRGD and HR9, in promoting docetaxel induced cytotoxicity in breast cancer cells | |
Dr. Katie Cich AACP-Walmart Scholar | PharmD, 2012, Summa Cum Laude | Clinical Pharmacist, Orlando VA, FL | |
Dr. Samreen Khatri AFPE Gateway and Pfizer Scholarship Award | PharmD, 2008, Cum Laude | Effect of methotrexate conjugated PAMAM dendrimers on the viability of MES-SA uterine cancer cells | Staff pharmacist, Richard L. Roudebush VA Medical Center, IN |
Dr. Brenda Greenen | PharmD, 2008, Cum Laude | In Vitro Dissolution of Buprenorphine Sublingual Tablets Using a Novel Flow-Through Apparatus | |
Dr. Amelia Brandt | PharmD, 2022 | Exosome: A biogenic Nanovesicle for Anticancer Drug Delivery | |
Mr. Madhu Surapaneni | MS graduate, 2004 | Development of a mucoadhesive formulation of pentoxifylline | Director, Business Operations, Pfizer, NY Previously: Bristol-Myers |
Ms. Swathi Pinnamaneni | MS graduate, 2002 | Nanoemulsion delivery system for tamoxifen | Principal Scientist, PTC Therapeutics, NJ Previously: Bristol-Myers |